IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q1 2022 Holdings

Filed 2022-05-11 | 5 holdings | $62.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$62.5M3,846,15499.7%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$131.7K1,111,1110.2%
Epizyme Inc(EPZMEUR)COM29428V104$47.8K31,833,3340.1%
Epizyme IncCallCOM29428V904$3.8K2,548,2840.0%
Viracta Therapeutics IncCOM92765F108$183,7000.0%